| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 1 buy and 16 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2020 | Francois Cedric78 | Chief Executive Officer | Sale+OE | 35,637 | $40.66 | $1,449,122.33 | -1.7% | |
| Feb 14, 2020 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $42.35 | $105,875.00 | -0.4% | |
| Feb 13, 2020 | Deschatelets Pascal69 | Chief Operating Officer | Sale+OE | 107,473 | $41.86 | $4,499,120.87 | -5.2% | |
| Feb 10, 2020 | Watson David O.70 | General Counsel | Sale+OE | 5,000 | $44.50 | $222,500.00 | -12.4% | |
| Jan 27, 2020 | Watson David O.70 | General Counsel | Sale+OE | 3,000 | $40.47 | $121,401.00 | -13.6% | |
| Jan 15, 2020 | Francois Cedric78 | Chief Executive Officer | Sale+OE | 35,638 | $42.11 | $1,500,787.50 | -1.2% | |
| Jan 15, 2020 | MacHiels Alec57 | Director | Sale+OE | 2,500 | $41.47 | $103,675.00 | -0.4% | |
| Jan 13, 2020 | Morningside Venture Investments Ltd93 | 10% Owner | Buy | 540,540 | $37.00 | $19,999,980.00 | +4.5% | |
| Dec 20, 2019 | Dunlop A. Sinclair62 | Director | Sell | 136,000 | $29.12 | $3,960,868.40 | -10.4% | |
| Dec 16, 2019 | Francois Cedric78 | Chief Executive Officer | Sell | 5,000 | $27.95 | $139,750.00 | -0.5% |